Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05566223
Title Phase 1/2 Study of CISH Inactivated TILs in the Treatment of NSCLC (CheckCell-2)
Acronym CheckCell-2
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Intima Bioscience, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field